Harvard Gets Down To Business With $50 Million For Biomedical Accelerator, MBA Program
This article was originally published in The Pink Sheet Daily
The university is setting up an evergreen translational research fund and a post-grad fellowship for the Harvard Business School with a donation from the foundation of Russian-born billionaire Len Blavatnik. The idea is to provide the financing and the business acumen to help life science research bridge the oft-noted valley of death.
You may also be interested in...
By seeding exploratory lab work across several biomedical and engineering disciplines, GlaxoSmithKline wants to understand how neural signals regulate diseases and eventually to design devices that can alter signals and provide therapeutic benefit.
Innovation, Prevention And Technology Transfer - China Releases Five-Year Plan For Medical Technology
Likely winners include new drug, medical device and traditional Chinese medicine manufacturers, according to analysts.
While public, regulatory and law enforcement attitudes toward marijuana in the U.S. continue to shift, it’s still tough to pursue legitimate clinical research on cannabis and cannabinoids. Could the exceptions slowly become the rule?